Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Twist Bioscience Corporation
TWST
$182.83
Name : Twist Bioscience Corporation
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $12,121,843,712.00
EPSttm : -2.23
finviz dynamic chart for TWST
Twist Bioscience Corporation
$182.83
0.65%
$1.20
TWST — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

19.57

Margin Of Safety %

Put/Call OI Ratio

0.56

EPS Next Q Diff

0.51

EPS Last/This Y

0.7

EPS This/Next Y

-0.03

Price

182.95

Target Price

116.27

Analyst Recom

1.83

Performance Q

83.12

Upside

-142.5%

Beta

2.22

Ticker: TWST




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-08-28TWST141.240.311.398582
2026-08-31TWST139.040.351.808972
2026-09-02TWST130.960.463.229202
2026-09-03TWST128.630.474.319297
2026-09-04TWST124.740.661.4610227
2026-09-08TWST127.860.670.7010381
2026-09-09TWST125.470.674.8210428
2026-09-10TWST1270.660.7610423
2026-09-11TWST127.20.661.3010498
2026-09-14TWST135.040.671.5410598
2026-09-15TWST137.220.672.0610764
2026-09-16TWST143.20.690.9710898
2026-09-17TWST155.640.710.7611220
2026-09-18TWST166.980.700.2812037
2026-09-21TWST165.790.550.739874
2026-09-22TWST164.540.550.629999
2026-09-23TWST158.480.562.8510132
2026-09-24TWST183.650.590.4710440
2026-09-25TWST182.950.560.4011558
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-08-28TWST141.4293.332.3-0.60
2026-08-31TWST138.8993.325.9-0.60
2026-09-01TWST132.0693.329.6-0.60
2026-09-02TWST131.0093.324.9-0.60
2026-09-03TWST128.9293.325.7-0.60
2026-09-04TWST124.7493.327.4-0.60
2026-09-08TWST127.8893.321.0-0.60
2026-09-10TWST126.8893.322.5-0.60
2026-09-11TWST127.1593.323.6-0.60
2026-09-14TWST134.7393.317.0-0.60
2026-09-15TWST137.9993.321.2-0.60
2026-09-16TWST137.9993.321.2-0.60
2026-09-17TWST155.6493.313.9-0.60
2026-09-18TWST166.9993.315.5-0.60
2026-09-21TWST165.7993.324.7-0.60
2026-09-22TWST164.5293.324.8-0.60
2026-09-23TWST158.5593.328.0-0.60
2026-09-24TWST184.0293.35.4-0.60
2026-09-25TWST182.9593.324.5-0.60
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-08-28TWST-20.010.5322.21
2026-08-31TWST-20.010.6122.19
2026-09-01TWST-20.240.6122.19
2026-09-02TWST-20.240.6122.19
2026-09-03TWST-21.490.6122.14
2026-09-04TWST-21.490.6122.14
2026-09-08TWST-21.490.7422.14
2026-09-09TWST-21.490.7422.14
2026-09-10TWST-21.610.7422.14
2026-09-11TWST-21.490.7418.93
2026-09-14TWST-21.493.7818.93
2026-09-15TWST-21.493.7818.93
2026-09-16TWST-21.543.7818.93
2026-09-17TWST-21.543.7818.93
2026-09-18TWST-21.543.7818.93
2026-09-21TWST-21.242.9618.93
2026-09-23TWST-30.582.9618.93
2026-09-24TWST-30.642.9618.93
2026-09-25TWST-32.132.9619.57
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

-0.56

Avg. EPS Est. Current Quarter

-0.03

Avg. EPS Est. Next Quarter

-0.05

Insider Transactions

-32.13

Institutional Transactions

2.96

Beta

2.22

Average Sales Estimate Current Quarter

123

Average Sales Estimate Next Quarter

125

Fair Value

Quality Score

33

Growth Score

44

Sentiment Score

92

Actual DrawDown %

1.2

Max Drawdown 5-Year %

-91.5

Target Price

116.27

P/E

Forward P/E

PEG

P/S

27.87

P/B

25.71

P/Free Cash Flow

EPS

-2.22

Average EPS Est. Cur. Y​

-0.6

EPS Next Y. (Est.)

-0.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-31.66

Relative Volume

1.53

Return on Equity vs Sector %

-56.9

Return on Equity vs Industry %

-37.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

24.5
◆ TWST Healthcare
$182.83
📉
Swing / Pullback
Buy the dip on strong trends
37 /100
WEAK
Trend
20/20
Pullback
4/25
Volume
3/15
Valuation
0/20
TP/AR
6/10
Options
4/10
RSI
73.4
Range 1M
94.8%
Sup Dist
9.5%
🚀
Momentum Growth
Ride accelerating trends
57 /100
WATCH
Momentum
19/25
Growth
12/30
Estimates
7/20
Inst/Vol
11/15
Options
8/10
EPS Yr
-65.9%
EPS NY
37.2%
52W%
97.9%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -36.4% upside
Quality
5/30
Valuation
0/30
Growth
10/25
Stability
8/10
LT Trend
4/5
Upside
-36.4%
Quality
33
TWST — P/E HistoricalDiagnostics & Research
Twist Bioscience Corporation
Sector: Healthcare
Industry: Biotechnology
Employees: 979
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc and Lilly TuneLab. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
TWST

Latest News

—
Caricamento notizie per TWST…
stock quote shares TWST – Twist Bioscience Corporation Stock Price stock today
news today TWST – Twist Bioscience Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch TWST – Twist Bioscience Corporation yahoo finance google finance
stock history TWST – Twist Bioscience Corporation invest stock market
stock prices TWST premarket after hours
ticker TWST fair value insiders trading